Upper digestive tract ulcer
Conditions
Interventions
control group:Lansoprazole,30mg 1/day,(HP infection addition Livzon Weisanlian)
experimental group:Combined with autologous PRP on the basis of standard treatment on the patients of control group
Sponsors
Transfusion department of Southwest hospital Chongqing China
Eligibility
Sex/Gender
Male
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1. Patients with upper gastrointestinal ulcer diagnosed by digestive endoscopy in Digestive System Department of our hospital; 2. Patients aged 18 to 60 (including 18 and 60 )years old, and gender not limited; 3. Patients without disease of hematopoietic system (blood routine inspection), and severe cardiopulmonary insufficiency (electrocardiogram and related symptoms); 4. Platelet count is more than 100*10^9/L; 5. Patients without Transfusion related diseases (AIDS, hepatitis c, hepatitis b, syphilis); 6. The patient or his legal representative signed on informed consent 7. Test result of pregnancy must be negative in women patient; 8. Patients can be cooperative on observation of curative effect and adverse reactions.
Exclusion criteria
Exclusion criteria: 1. Patients with aged younger than 18 years or older than 60 years, or with a definitive diagnosis of malignant ulcer ; 2. Patients with dysplasia of Hematopoietic system(blood routine inspection); 3. Platelet count is less than 100*10^9/L; 4. Patients with severe cardiopulmonary insufficiency (electrocardiogram and related symptoms); 5. Pregnancy or breast-feeding women; 6. Patients with any one of Transfusion related diseases (AIDS, hepatitis c, hepatitis b, syphilis); 7. The patient or his legal representative did not signe on informed consent; 8. Patients can not be cooperative on observation of curative effect and adverse reactions.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| area of ulcer; | — |
Countries
China
Contacts
Public ContactHua Lu
Outcome results
None listed